275 related articles for article (PubMed ID: 18454570)
1. Epidemiology and management options for colorectal cancer in children.
Saab R; Furman WL
Paediatr Drugs; 2008; 10(3):177-92. PubMed ID: 18454570
[TBL] [Abstract][Full Text] [Related]
2. [Recent results of irinotecan therapy in colorectal cancer].
Láng I; Hitre E
Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
[TBL] [Abstract][Full Text] [Related]
3. Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China.
Xu R; Wang W; Zhu B; Lin X; Ma D; Zhu L; Zhao Q; Nie Y; Cai X; Li Q; Fang W; Li H; Wang N; Chen Y; Peng C; Fang H; Shen L
BMC Cancer; 2020 Feb; 20(1):131. PubMed ID: 32070312
[TBL] [Abstract][Full Text] [Related]
4. Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy.
Ferrari A; Rognone A; Casanova M; Zaffignani E; Piva L; Collini P; Bertario L; Sala P; Leo E; Belli F; Gallino G
Pediatr Blood Cancer; 2008 Mar; 50(3):588-93. PubMed ID: 17405155
[TBL] [Abstract][Full Text] [Related]
5. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review.
Hill DA; Furman WL; Billups CA; Riedley SE; Cain AM; Rao BN; Pratt CB; Spunt SL
J Clin Oncol; 2007 Dec; 25(36):5808-14. PubMed ID: 18089879
[TBL] [Abstract][Full Text] [Related]
6. Early-onset colorectal cancer in young individuals.
Mauri G; Sartore-Bianchi A; Russo AG; Marsoni S; Bardelli A; Siena S
Mol Oncol; 2019 Feb; 13(2):109-131. PubMed ID: 30520562
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
Tappenden P; Jones R; Paisley S; Carroll C
Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
[TBL] [Abstract][Full Text] [Related]
8. Management and pharmacotherapy of pediatric colorectal carcinoma: a review.
Bergamaschi L; Chiaravalli S; Signoroni S; Di Bartolomeo M; Ferrari A
Expert Opin Pharmacother; 2023; 24(14):1527-1535. PubMed ID: 37358925
[TBL] [Abstract][Full Text] [Related]
9. Management of colorectal carcinoma in children and young adults.
Goldberg J; Furman WL
J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S76-9. PubMed ID: 22525412
[TBL] [Abstract][Full Text] [Related]
10. Adolescent and young adult colorectal cancer.
Hubbard JM; Grothey A
J Natl Compr Canc Netw; 2013 Oct; 11(10):1219-25. PubMed ID: 24142823
[TBL] [Abstract][Full Text] [Related]
11. [Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer].
Cai Y; Deng R; Hu H; Zhang J; Ling J; Wu Z; Yang L; Li J; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1045-1050. PubMed ID: 30269326
[TBL] [Abstract][Full Text] [Related]
12. The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment.
Connell LC; Mota JM; Braghiroli MI; Hoff PM
Curr Treat Options Oncol; 2017 Apr; 18(4):23. PubMed ID: 28391421
[TBL] [Abstract][Full Text] [Related]
13. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Lin WR; Chiang JM; Liang KH; Lim SN; Lai MW; Tsou YK; Hsieh TY; Hsu CK; Yeh CT
Medicine (Baltimore); 2016 Apr; 95(17):e3487. PubMed ID: 27124048
[TBL] [Abstract][Full Text] [Related]
14. FOLFIRI-bevacizumab as first-line chemotherapy in 3500 patients with advanced colorectal cancer: a pooled analysis of 29 published trials.
Petrelli F; Borgonovo K; Cabiddu M; Ghilardi M; Lonati V; Maspero F; Sauta MG; Beretta GD; Barni S
Clin Colorectal Cancer; 2013 Sep; 12(3):145-51. PubMed ID: 23763824
[TBL] [Abstract][Full Text] [Related]
15. Treatment of colorectal liver metastases: a review.
Van den Eynde M; Hendlisz A
Rev Recent Clin Trials; 2009 Jan; 4(1):56-62. PubMed ID: 19149763
[TBL] [Abstract][Full Text] [Related]
16. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.
Debunne H; Ceelen W
Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463
[TBL] [Abstract][Full Text] [Related]
17. Update on clinical data combining capecitabine with targeted agents in newly diagnosed colorectal cancer.
Lee JJ; Chu E
Clin Colorectal Cancer; 2007 Dec; 7 Suppl 1():S16-20. PubMed ID: 18361802
[TBL] [Abstract][Full Text] [Related]
18. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome?
Dozois EJ; Boardman LA; Suwanthanma W; Limburg PJ; Cima RR; Bakken JL; Vierkant RA; Aakre JA; Larson DW
Medicine (Baltimore); 2008 Sep; 87(5):259-263. PubMed ID: 18794708
[TBL] [Abstract][Full Text] [Related]
19. Colon carcinoma in childhood: review of the literature with four case reports.
Kim G; Baik SH; Lee KY; Hur H; Min BS; Lyu CJ; Kim NK
Int J Colorectal Dis; 2013 Feb; 28(2):157-64. PubMed ID: 23099637
[TBL] [Abstract][Full Text] [Related]
20. Advances in the management of colorectal cancer: from biology to treatment.
Ahmed S; Johnson K; Ahmed O; Iqbal N
Int J Colorectal Dis; 2014 Sep; 29(9):1031-42. PubMed ID: 24953060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
